FDA 483 - Kerber USA Inc. - November 02, 2022

During an FDA inspection conducted from October 31 to November 2, 2022, medical device manufacturer Kerber USA Inc., located in Amherst, NY, received a Form FDA 483 outlining significant quality system deficiencies. The inspection revealed a systemic lack of established procedures critical for ensuring product quality and safety, as required by medical device regulations.